Who makes ASLAN003 ACTIVE?

ASLAN003 ACTIVE is developed by ASLAN Pharmaceuticals.

Last reviewed 2026-04-20 · How we verify

ASLAN003 ACTIVE

ASLAN Pharmaceuticals · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	ASLAN003 ACTIVE
Also known as	ASLAN 003 , LAS186323
Sponsor	ASLAN Pharmaceuticals
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003 (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ASLAN003 ACTIVE CI brief — competitive landscape report
ASLAN003 ACTIVE updates RSS · CI watch RSS
ASLAN Pharmaceuticals portfolio CI